NSCLC ADENOCARCINOMA

Clinical trials for NSCLC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new NSCLC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for NSCLC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New hope for Tough-to-Treat cancers: experimental drug enters human trials

Disease control Not yet recruiting

This study is testing an experimental drug called atamparib in adults with advanced lung cancer or other solid tumors that have spread. It aims to find the safest dose and see if the drug can shrink tumors in people who have already tried standard treatments and have a specific g…

Matched conditions: NSCLC ADENOCARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: Nerviano Medical Sciences (Shanghai) Ltd. • Aim: Disease control

Last updated Apr 01, 2026 23:11 UTC

NSCLC ADENOCARCINOMA

Get alerted when new NSCLC ADENOCARCINOMA trials appear

New hope for Tough-to-Treat cancers: experimental drug enters human trials